Dobutamine myocardial scintigraphy for the prediction of cardiac events after heart transplantation

Nuclear Medicine Communications

Volumn 26, Issue 7, 2005, Pages 607-612

  Hacker, Marcus ^a   Tausig, Andreas ^a   Romüller, Bernd ^a   Hoyer, Xaver ^a   Klauss, Volker ^a   Stempfle, Ulrich ^a   Reichart, Bruno ^a   Hahn, Klaus ^a   Tiling, Reinhold ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiac allograft vasculopathy; Cardiac events; Coronary angiography; Follow up; Heart transplantation; Myocardial perfusion scintigraphy

Indexed keywords

DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEART SCINTISCANNING; HEART TRANSPLANTATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; RADIATION ATTENUATION; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUMMED REST SCORE; SUMMED STRESS SCORE;

CORONARY DISEASE; DOBUTAMINE; EXERCISE TEST; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 21344435511     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000167908.30977.fe     Document Type: Article

References (56)

1. Grant SC, Brooks NH, Levy RD. Routine coronary angiography after heart transplantation. Heart 1997; 78:101-102.
2. Hosenpud JD. Coronary artery disease after heart transplantation and its relation to cytomegalovirus. Am Heart J 1999; 138:S469-S472.
3. Kaye MP. The Registry of the International Society for Heart and Lung Transplantation: tenth official report - 1993. J Heart Lung Transplant 1993; 12:541-548.
4. Eich D, Thompson JA, Ko DJ, Hastillo A, Lower R, Katz S, et al. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant 1991; 10:45-49.
5. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989; 30:1182-1191.
6. Wilson RF, Christensen BV, Olivari MT, Simon A, White CW, Laxson DD. Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans. Circulation 1991; 83:1210-1220.
7. Lietz K, Miller LW. Current understanding and management of allograft vasculopathy. Semin Thorac Cardiovasc Surg 2004; 16:386-394.
8. von Scheidt W. Cardiac allograft vasculopathy - problem and model. Z Kardiol 2000; 89:IX/2-5.
9. Weis M, von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 1997; 96:2069-2077.
10. Mehra MR, Benza R, Deng MC, Russell S, Webber S. Surrogate markers for late cardiac allograft survival. Am J Transplant 2004; 4:1184-1191.
11. Bacal F, Moreira L, Souza G, Rodrigues AC, Fiorelli A, Stolf N, et al. Dobutamine stress echocardiography predicts cardiac events or death in asymptomatic patients long-term after heart transplantation: 4-year prospective evaluation. J Heart Lung Transplant 2004; 23:1238-1244.
12. Elhendy A, Sozzi FB, van Domburg RT, Vantrimpont P, Valkema R, Krenning EP, et al. Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis. J Heart Lung Transplant 2000; 19:360-366.
13. Ciliberto GR, Ruffini L, Mangiavacchi M, Parolini M, Sara R, Massa D, et al. Resting echocardiography and quantitative dipyridamole technetium-99-m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation. Eur Heart J 2001; 22:964-971.
14. Fang JC, Rocco T, Jarcho J, Ganz P, Mudge GH. Noninvasive assessment of transplant-associated arteriosclerosis. Am Heart J 1998; 135:980-987.
15. Redonnet M, Derumeaux G, Mouton-Schleifer D, Litzler PY, Segond G, Bouchart F, et al. Noninvasive detection of cardiac graft vascular disease. Transplant Proc 1995; 27:2530-2531.
16. Howarth DM, Forstrom LA, Samudrala V, Sinak LJ, McGregor CG, Rodeheffer RJ, et al. Evaluation of 201Tl SPET myocardial perfusion imaging in the detection of coronary artery disease after orthotopic heart transplantation. Nucl Med Commun 1996; 17:105-113.
17. Legare JF, Haddad H, Barnes D, Sullivan JA, Buth KJ, Hirsch G. Myocardial scintigraphy correlates poorly with coronary angiography in the screening of transplant arteriosclerosis. Can J Cardiol 2001; 17:866-872.
18. Nishimura RA, Edwards WD, Warnes CA, Reeder GS, Holmes DR, Tajik AJ, et al. Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol 1990; 16:145-154.
19. Ventura HO, Ramee SR, Jain A, White CJ, Collins TJ, Mesa JE, et al. Coronary artery imaging with intravascular ultrasound in patients following cardiac transplantation. Transplantation 1992; 53:216-219.
20. von Scheidt W. The clinical dilemma of cardiac allograft vasculopathy - an introduction to the clinical session. Z Kardiol 2000; 89(suppl 9):IX/40-44.
21. Spes CH, Angermann CE. Stress echocardiography for assessment of cardiac allograft vasculopathy. Z Kardiol 2000; 89(suppl 9):IX/50-53.
22. Yen RF, Ho YL, Chou NK, Hsu RB, Huang PJ. Inhomogeneity of myocardial perfusion in heart transplant recipients: evaluation with dobutamine thallium-201 SPECT. Nucl Med Commun 2001; 22:1015-1019.
23. Verhoeven PP, Lee FA, Ramahi TM, Franco KL, Mendes de Leon C, Amatruda J, et al. Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation. J Am Coll Cardiol 1996; 28:183-189.
24. Elhendy A, van Domburg RT, Vantrimpont P, Poldermans D, Bax JJ, van Gelder T, et al. Prediction of mortality in heart transplant recipients by stress technetium-99-m tetrofosmin myocardial perfusion imaging. Am J Cardiol 2002; 89:964-968.
25. Spes CH, Mudra H, Schnaack SD, Klauss V, Reichle FM, Uberfuhr P, et al. Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound. Am J Cardiol 1996; 78:168-174.
26. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97:535-543.
27. Imaging guidelines for nuclear cardiology procedures, part 2. American Society of Nuclear Cardiology. J Nucl Cardiol 1999; 6:G47-G84.
28. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
29. Uberla KK, Schreiber MA. Statistical instruments in medical prognosis. Internist (Berl) 1981; 22:124-130.
30. Pinney SP, Mancini D. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment. Curr Opin Cardiol 2004; 19:170-176.
31. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant 1992; 11:9-23.
32. Spes CH, Klauss V, Mudra H, Schnaack SD, Tammen AR, Rieber J, et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. Circulation 1999; 100:509-515.
33. Everett JP, Hershberger RE, Ratkovec RM, Norman DJ, Cobanoglu A, Ott GY, et al. The specificity of normal qualitative angiography in excluding cardiac allograft vasculopathy. J Heart Lung Transplant 1994; 13:142-149.
34. Uretsky BF, Kormos RL, Zerbe TR, Lee A, Tokarczyk TR, Murali S, et al. Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography. J Heart Lung Transplant 1992; 11:S45-S51.
35. Preumont N, Berkenboom G, Vachiery J, Jansens J, Antoine M, Wikler D, et al. Early alterations of myocardial blood flow reserve in heart transplant recipients with angiographically normal coronary arteries. J Heart Lung Transplant 2000; 19:538-545.
36. Halle AA, DiSciascio G, Massin EK, Wilson RF, Johnson MR, Sullivan HJ, et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 1995; 26:120-128.
37. Heublein B, Pethig K, Maass C, Wahlers T, Haverich A. Coronary artery stenting in cardiac allograft vascular disease. Am Heart J 1997; 134:930-938.
38. Wong PM, Piamsomboon C, Mathur A, Chastain HD, Singh DJ, Liu MW, et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol 1998; 82:239-241.
39. Benza RL, Zoghbi GJ, Tallaj J, Brown R, Kirklin JK, Hubbard M, et al. Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience. J Am Coll Cardiol 2004;43: 1973-1981.
40. Doshi AA, Rogers J, Kern MJ, Hauptman PJ. Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. Am J Cardiol 2004; 93:90-92.
41. Eisen H, Ross H. Optimizing the immunosuppressive regimen in heart transplantation. J Heart Lung Transplant 2004; 23:S207-S213.
42. Hoffman R, Lethen H, Kleinhans E, Kruger S, Flachskampf FA, Hanrath P. Dobutamine stress echocardiography and perfusion scintigraphy for detection of myocardial ischemia in patients with and without previous myocardial infarct. Z Kardiol 1996; 85:20-27.
43. Underwood SR, Godman B, Salyani S, Ogle JR, Ell PJ. Economics of myocardial perfusion imaging in Europe - the EMPIRE Study. Eur Heart J 1999; 20:157-166.
44. Elhendy A, van Domburg RT, Bax JJ, Poldermans D, Sozzi FB, Roelandt JR. Accuracy of dobutamine technetium 99-m sestamibi SPECT imaging for the diagnosis of single-vessel coronary artery disease: comparison with echocardiography. Am Heart J 2000; 139:224-230.
45. Rodney RA, Johnson LL, Blood DK, Barr ML. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium 99-m sestamibi. J Heart Lung Transplant 1994; 13:173-180.
46. Ciliberto GR, Mangiavacchi M, Banfi F, Massa D, Danzi G, Cataldo G, et al. Coronary artery disease after heart transplantation: non-invasive evaluation with exercise thallium scintigraphy. Eur Heart J 1993; 14:226-229.
47. Puskas C, Kosch M, Kerber S, Jonas M, Weyand M, Breithardt G, et al. Progressive heterogeneity of myocardial perfusion in heart transplant recipients detected by thallium-201 myocardial SPECT. J Nucl Med 1997; 38:760-765.
48. Smart FW, Ballantyne CM, Cocanougher B, Farmer JA, Sekela ME, Noon GP, et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol 1991; 67:243-247.
49. La Scola B, Fenollar F, Fournier PE, Altwegg M, Mallet MN, Raoult D. Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus. Int J Syst Evol Microbiol 2001; 51:1471-1479.
50. Weis M, Hartmann A, Olbrich HG, Hor G, Zeiher AM. Prognostic significance of coronary flow reserve on left ventricular ejection fraction in cardiac transplant recipients. Transplantation 1998; 65:103-108.
51. De Chiara B, Bigi R, Devoto E, Cavenaghi G, Turazza F, Sara R, et al. Usefulness of chronotropic incompetence to dipyridamole in predicting myocardial perfusion defects in heart transplant recipients. Am J Cardiol 2003; 92:1001-1004.
52. Akosah KO, Mohanty PK. Role of dobutamine stress echocardiography in heart transplant patients. Chest 1998; 113:809-815.
53. Gerber BL, Bernard X, Melin JA, Delestinne T, Vanbutsele R, Goenen M, et al. Exaggerated chronotropic and energetic response to dobutamine after orthotopic cardiac transplantation. J Heart Lung Transplant 2001; 20:824-832.
54. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 1991; 83:363-381.
55. Brown KA. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol 1996; 3:516-537.
56. Carlsen J, Toft JC, Mortensen SA, Arendrup H, Aldershvile J, Hesse B. Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients. J Heart Lung Transplant 2000; 19:873-878.